Elanco Animal Health (ELAN) Interest Coverage Ratio Growth (3y) (2021 - 2026)
Elanco Animal Health (ELAN) Interest Coverage Ratio Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | -75.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.62% |
| Mar 31, 2026 | 41.72% |
| Dec 31, 2025 | 55.33% |
| Sep 30, 2025 | 33.14% |
| Jun 30, 2025 | 33.77% |
| Mar 31, 2025 | 45.47% |
| Dec 31, 2024 | -1.30% |
| Sep 30, 2024 | 28.25% |
| Jun 30, 2024 | 14.85% |
| Mar 31, 2024 | 10.34% |
| Dec 31, 2023 | 36.94% |
| Sep 30, 2023 | -49.06% |
| Jun 30, 2023 | 22.55% |
| Mar 31, 2023 | 37.80% |
| Dec 31, 2022 | 34.70% |
| Sep 30, 2022 | 27.53% |
| Jun 30, 2022 | 23.06% |
| Mar 31, 2022 | 27.12% |
| Dec 31, 2021 | 16.38% |
| Sep 30, 2021 | 32.23% |